Flavopiridol in Treating Patients With Locally Advanced or Metastatic Solid Tumors

This study is ongoing, but not recruiting participants.

Study NCT00112684 Information provided by National Cancer Institute (NCI)

First Received: June 2, 2005 Last Updated: February 4, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2006 (Final data collection date for primary outcome measure)

Publications:

Ramaswamy B, Lai JP, Phelps M, et al.: A phase I study of flavopiridol using an alternative schedule of 30-min loading dose followed by a 4-hour IV infusion in patients (pts) with advanced solid tumors. [Abstract] American Association for Cancer Research: 98th Annual Meeting, April 14-18, 2007, Los Angeles, CA. A-925, 2007.